Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof and a component selected from the group consisting of an unsaturated lipid, phenylethylamine, a soluble calcium compound, or a combination thereof.